Eco Animal Health Group PLC New Banking Facility (9208R)

TIDMEAH

RNS Number : 9208R

Eco Animal Health Group PLC

11 July 2022

11 July 2022

ECO Animal Health Group plc

("ECO", the "Company" or the "ECO Group") (AIM: EAH)

New Banking Facility

ECO Animal Health Group plc, a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, is pleased to announce that it has signed a new bank facility agreement with its bank, National Westminster Bank plc ("NatWest").

The new facility is a Revolving Credit Facility ("RCF") and will provide for drawings of up to GBP10 million in flexible amounts and repayment periods. The facility has a term expiring on 30 June 2026. The interest rate is 1.95% plus the Sterling Overnight Index Average lending rate. Covenants, comprising customary leverage and interest cover tests, are reported six monthly to NatWest, co-incident with ECO's AIM financial reporting obligations.

The facility is in addition to the Company's pre-existing GBP5 million overdraft facility. Pre-existing security arrangements support the new facility.

The RCF will provide structured working capital support. Whilst it is not intended that the RCF will directly fund any elements of the R&D programme, its existence will ensure that the ECO Group will have the confidence to progress the new product development programme and deal with working capital movements.

Christopher Wilks, Chief Financial Officer of ECO said: "I am very pleased to have signed this facility with NatWest; it will provide the flexibility to fund working capital movements in these uncertain times and allow us to use our core cash generated from operations to fund our exciting R&D projects."

The information contained within this announcement is deemed by the Group to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR") as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

For further information please contact:

 
 ECO Animal Health Group plc 
  David Hallas (CEO) 
  Christopher Wilks (CFO)                       020 8447 8899 
 
   IFC Advisory 
   Graham Herring 
   Zach Cohen                                     020 3934 6630 
 
   Singer Capital Markets (Nominated Adviser 
   & Joint Broker) 
   Mark Taylor 
   George Tzimas                                  020 7496 3000 
 
   Investec (Joint Broker) 
   Gary Clarence 
   Brough Ransom                                  020 7597 5970 
   Carlo Spingardi 
 
   Peel Hunt LLP (Joint Broker) 
   Dr Christopher Golden 
   James Steel                                    020 7418 8900 
 
 
 Equity Developments 
  Hannah Crowe 
  Matt Evans            020 7065 2692 
 

About ECO Animal Health

ECO Animal Health Group plc researches, develops and commercialises products for livestock. Our business strategy is to generate shareholder value by achieving the maximum sales potential from the existing product portfolio whilst investing in Research and Development ("R&D") for new products, particularly vaccines, and seeking to in-license new products.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCRPMRTMTJMBMT

(END) Dow Jones Newswires

July 11, 2022 02:00 ET (06:00 GMT)